$40 – $55

VALUE-BASED CARE: HOW MANUFACTURERS, PROVIDERS, AND PAYERS ARE PREPARING FO...

Event Information

Share this event

Date and Time

Location

Location

FOLEY HOAG LLP

Seaport West

155 Seaport Boulevard

Boston, MA 02210

View Map

Refund Policy

Refund Policy

Refunds up to 1 day before event

Event description

Description

New England Healthcare Executive network Meeting

April 1, 2019, 7:30AM to 10:00AM

Value-Based Care

How Manufacturers, Providers, and Payers are Preparing for a Changing Environment


Location
FOLEY HOAG LLP, Seaport West, 155 Seaport Boulevard, Boston
For Driving and Parking Information, Click Here.


Program Description

Hear from industry leaders on how to be successful in a new value-based care world.

Pharma and MedTech companies are struggling to understand the speed and impact of the value-based care transition in the U.S. healthcare system. While providers are working hard to comply with new changes driven by CMS and private payers, many companies wonder if the transition will be implemented as quickly as some stakeholders are claiming.

According to CMS sources, by 2020, 80% of the $3 trillion in U.S. healthcare spending will be tied to quality measures or value-based models. Are Pharma and MedTech companies ready for this rapid change? Will value-based care and pay for performance truly improve the U.S. healthcare system?

Keynote Speaker

Deepak Sahu, Manager, Alira Health

Deepak is a manager in the MA/HEOR and Value-Based Payment Modeling practice at Alira Health. He works with Medtech and Pharma companies, guiding their evolution from product suppliers to solution providers in the U.S. healthcare ecosystem.

Moderator

Gabriele Brambilla, Chief Executive Officer, Alira Health

Alira Health is an international advisory firm providing integrated advisory services throughout the continuum of both the corporate and product lifecycle.

Panelists

Corbin Petro, President & Chief Executive Officer, Benevera Health

As President and CEO, Petro directs operations and strategy for Benevera Health and co-leads Harvard Pilgrim's New Hampshire insurance business.

Scott Reid, VP, Healthcare Strategy & Reimbursement, Smith & Nephew

Scott leads the US healthcare strategy and reimbursement team to secure appropriate payment for the full range of S&N products across all relevant sites of care.

Gary Trendel, Group Manager, Enterprise Marketing Strategy, Boston Scientific

Gary is a global marketing leader with an exceptional record of customer focus, innovative strategic planning, and marketing reform towards value-based healthcare.

Come join this timely, lively, keynote presentation and blue-ribbon panel discussion. Ask questions and contribute your insights during the interactive audience segment.

What to Expect

The speakers will address these topics among others:

  • How fast is the transition to value-based care happening?
  • How are major stakeholders addressing this transition, and what types of strategies have been implemented?
  • Does everyone agree that value-based care is the answer to improving the U.S. healthcare system?
  • Are certain segments implementing changes faster than others?
  • Will Pharma and MedTech players need to materially change the way they approach sales and marketing?
  • Will some stakeholders have to reinvent their role in the healthcare ecosystem (e.g. GPOs, independent physician practices)?

Who should attend

C-level executives, board members, healthcare providers, venture capital and private equity investors, anyone who wants a better understanding of how value-based care will change the different dynamics and roles in the U.S. healthcare ecosystem.

Speaker Bios

Gabriele Brambilla, Chief Executive Officer, Alira Health

Since 2010, Gabriele Brambilla has been responsible for running Alira Health’s US location in Boston, Massachusetts. In 2014, Gabriele became CEO of Alira Health. He has run strategy projects in fluid management, medical imaging and infection control. During his time with Alira Health, Gabriele has developed a strong expertise in the medical device contract manufacturing market and has executed many M&A projects in that specific segment.

Before his time at Alira Health, Gabriele Brambilla received his BA in Political Science from the University of Pavia, a Master in International Affairs from the I.S.P.I. and an MBA from Post Graduate SDA Bocconi – both in Milan, Italy. He began his career in Shanghai (China) working for an Italian Pharmaceutical Company with a business partner selection task.

Corbin Petro, President and CEO, Benevera Health

Benevera Health is a Population Health company and payer/provider joint venture. In her role as President and CEO, Petro directs operations and strategy for Benevera Health and co-leads Harvard Pilgrim’s New Hampshire insurance business.

Previously, Petro was Chief Operating Officer (COO) of the Massachusetts Department of Medicaid (MassHealth) where she oversaw operations, IT functions, and several program areas for the $13 billon agency providing health care to 1.4 million Massachusetts residents. Petro has an extensive background in healthcare including advising a US Senator on health reform, and roles at Bain and Company, Goldman Sachs, Deloitte Consulting, and American Management Systems.

Petro received a BA from Yale University and an MBA from the Wharton School at the University of Pennsylvania.

Scott Reid, VP, Healthcare Strategy & Reimbursement, Smith & Nephew

Scott leads the US healthcare strategy and reimbursement team to secure appropriate payment for the full range of S&N products across all relevant sites of care.

Deepak Sahu, Manager, Alira Health

Deepak focuses on public health and has a strong background in healthcare solutions development. He has strategy consulting and project management experience from engagements in Japan, US and Europe. With Alira Health, Deepak has advised various med-tech and pharma companies to improve their Market Access processes by implementing in-depth health economic and epidemiology studies. Deepak has successfully presented Alira Health’s technological innovations at various international congresses such as the American College of Cardiology (ACC). Early in his career, he worked at Samsung’s R&D department. Deepak holds an MBA from ESB Business School in Germany and Bachelors in Computer Science.

Gary Trendel, Group Manager, Enterprise Marketing Strategy, Boston Scientific

Gary Trendel is Group Manager, Enterprise Marketing Strategy. In his role, he is specifically focused on transforming Boston Scientific’s VBHC (Value Based Healthcare) capabilities, and he also has oversight for economic customer insights, competitive intelligence and MBA recruiting. Gary has been at Boston Scientific since 2006, and has previously worked in the Urology, Peripheral Interventions, and Endoscopy divisions in multiple product management and marketing roles. He has established himself in Boston Scientific as a marketing leader with an innate ability to translate deep customer and market insights into meaningful and actionable strategy.

Prior to Boston Scientific, Gary worked at Johnson & Johnson and BOC Gases. He holds a BS in civil engineering from Carnegie Mellon University and an MBA from Duke University. Gary lives in Hopkinton, Massachusetts with his wife and three daughters. He is actively involved in his community as a member of the planning board, and he also coaches his girls in basketball, soccer, and softball.




SPONSORSHIP KINDLY PROVIDED BY:

Alira Health







Swifton CFOs

Share with friends

Date and Time

Location

FOLEY HOAG LLP

Seaport West

155 Seaport Boulevard

Boston, MA 02210

View Map

Refund Policy

Refunds up to 1 day before event

Save This Event

Event Saved